Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
British Journal of Cancer
|
May 9, 2013
Assessment of DNA methylation status in early stages of breast cancer development
A Q van Hoesel, Y Sato, D A Elashoff, et al.
Breast Cancer Research and Treatment
|
April 12, 2011
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer
Anneke Q van Hoesel, Cornelis J H van de Velde, Peter J K Kuppen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
G Giaccone, T A Splinter, C Debruyne, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 10, 2014
Age-dependent clinical prognostic value of histone modifications in colorectal cancer
Inès J Goossens-Beumer, Anne Benard, Anneke Q van Hoesel, et al.
Histopathology
|
October 14, 2014
Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer
Anne Benard, Inès J Goossens-Beumer, Anneke Q van Hoesel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
O S Nielsen, I Judson, Q van Hoesel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
I Judson, J A Radford, M Harris, et al.
BMC Cancer
|
August 21, 2014
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
Remco S Derr, Anneke Q van Hoesel, Anne Benard, et al.
Gynecologic Oncology
|
May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
H C Wagenaar, N Colombo, I Vergote, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
British Journal of Cancer
|
May 9, 2013
Assessment of DNA methylation status in early stages of breast cancer development
A Q van Hoesel, Y Sato, D A Elashoff, et al.
Breast Cancer Research and Treatment
|
April 12, 2011
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer
Anneke Q van Hoesel, Cornelis J H van de Velde, Peter J K Kuppen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
G Giaccone, T A Splinter, C Debruyne, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 10, 2014
Age-dependent clinical prognostic value of histone modifications in colorectal cancer
Inès J Goossens-Beumer, Anne Benard, Anneke Q van Hoesel, et al.
Histopathology
|
October 14, 2014
Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer
Anne Benard, Inès J Goossens-Beumer, Anneke Q van Hoesel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
O S Nielsen, I Judson, Q van Hoesel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
I Judson, J A Radford, M Harris, et al.
BMC Cancer
|
August 21, 2014
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
Remco S Derr, Anneke Q van Hoesel, Anne Benard, et al.
Gynecologic Oncology
|
May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
H C Wagenaar, N Colombo, I Vergote, et al.
Page
of 3